Page 10 - Logix Smart News Today

Are These The Best Medical Diagnostic Stocks To Buy Right Now? Medical diagnostic stocks are a branch of health care stocks in the stock market. As the name suggests, these are companies that specialize in diagnostic testing and equipment. The importance of a good diagnosis should not be understated. Accurate and efficient diagnostic procedures are essential for doctors to create a proper treatment plan that would fully benefit the patient. A fatal disease can be detected early with proper diag...

) NA Proactive news snapshot: Canada Silver Cobalt Works, Benchmark Metals, Empress Royalty, Boosh Plant-Based Brands UPDATE ... A glance at some of the days highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Canada Silver Cobalt Works Inc is set to start a drill program in the next 30 days at its Graal-Nourricier - Lac Suzanne property in Quebec following the receipt of a drill permit. The asset is one of 15 properties ...

Author Bio Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles. What happened The roller-coaster-like trajectory that has been Co-Diagnostics (NASDAQ:CODX) stock price climbed another hill on Thursday. The heal...

NA Proactive news snapshot: Snowline Gold, Endeavour Mining, Playgon Games, KULR Technology Group UPDATE … A glance at some of the days highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Snowline Gold Corp (CSE:SGD) (OTCPINK:SNWGF) has said that it will initiate a fully funded 2021 exploration program in the first week of June at its flagship Einarson and Rogue projects in Yukon’s metal-rich Selwyn Basin, in Canada. T...

Co-Diagnostics turns 1Q net profit of nearly $8M on strong sales of its Logix Smart COVID-19 Test Fueled by $20 million in revenue, net income was $7.9 million as compared to a net loss of $1.1 million in the prior-year quarter Looking to the second quarter, Co-Diagnostics gave revenue guidance in the range of $20 million to $22 million Co-Diagnostics Inc (NASDAQ:CODX) reported that it earned a first-quarter net profit -- versus a loss last year -- on strong sales of its Logix Sma...

Share this article SALT LAKE CITY, May 13, 2021 /PRNewswire/ -- Co-Diagnostics, Inc.  (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today financial results for the first quarter ended March 31, 2021. First-Quarter 2021 Financial Results: Strong quarterly results highlighted by revenue of $20.0 million, pre-tax income of $9.9 million, diluted EPS of $0.26 Revenue of $20.0 million, primarily due to s...

-- Co-Diagnostics, Inc.  (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its Logix Smart™ COVID-19 Test Kit was used by Australian researchers to demonstrate rapidly deployable mobile molecular diagnostics support for remote locations, with the peer-reviewed results published in the Journal of Medical Microbiology. The study was performed using readily available open-source equipment and materia...

NA Proactive news snapshot: Snowline Gold, PharmaDrug, Fortitude Gold, Cloud Nine Web3 Technologies UPDATE … A glance at some of the days highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Snowline Gold Corp (CSE:SGD) has told shareholders that its Cynthia gold project in Yukon has both bulk tonnage and high-grade exploration potential. Located in the Selwyn Basin, Cynthia covers a four-square-kilometre area of gold mine...

Co-Diagnostics says Logix Smart COVID-19 Test performance validated by Australian researchers in peer-reviewed publication A paper published in the Journal of Medical Microbiology utilizes the companys Logix Smart COVID-19 Test Kit in rapidly deployable mobile molecular diagnostics Co-Diagnostics CEO Dwight Egan said the results of the independent peer-reviewed paper further establishes the robustness, versatility, and quality of our Logix Smart COVID-19 diagnostic Co-Diagnostics In...

Share this article SALT LAKE CITY, Feb. 16, 2021 /PRNewswire/ -- Co-Diagnostics, Inc.  (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it will be presenting on direct saliva testing for COVID-19 at the 28 th Annual International Molecular Medicine Tri-Conference, held virtually on February 16-18, 2021. Company representatives will introduce the Co-Diagnostics Logix Smart SARS-CoV-2 DS (Direct Saliva...